Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 6833

1.

The safety of human papilloma virus-blockers and the risk of triggering autoimmune diseases.

Baker B, Eça Guimarães L, Tomljenovic L, Agmon-Levin N, Shoenfeld Y.

Expert Opin Drug Saf. 2015 Jul 27:1-8. [Epub ahead of print]

PMID:
26216756
2.

Therapeutic cancer vaccines.

Melief CJ, van Hall T, Arens R, Ossendorp F, van der Burg SH.

J Clin Invest. 2015 Jul 27:1-12. doi: 10.1172/JCI80009. [Epub ahead of print]

PMID:
26214521
3.

Vaccination of adolescents with chronic medical conditions: Special considerations and strategies for enhancing uptake.

Hofstetter AM, LaRussa P, Rosenthal SL.

Hum Vaccin Immunother. 2015 Jul 25:0. [Epub ahead of print]

PMID:
26212313
4.

Identification of immunotherapeutic epitope of E5 protein of human papillomavirus-16: An in silico approach.

Kumar A, Yadav IS, Hussain S, Das BC, Bharadwaj M.

Biologicals. 2015 Jul 24. pii: S1045-1056(15)00082-2. doi: 10.1016/j.biologicals.2015.07.002. [Epub ahead of print]

PMID:
26212000
5.

Evaluation of the immunogenicity of the quadrivalent HPV vaccine using two versus three doses at month 21: An epidemiological surveillance mechanism for alternate vaccination schemes.

Hernández-Ávila M, Torres L, Stanley M, Salmerón J, Cruz-Valdez A, Muñoz N, Herrero R, Villaseñor-Ruíz IF, Lazcano-Ponce E.

Hum Vaccin Immunother. 2015 Jul 25:0. [Epub ahead of print]

PMID:
26211489
6.

Attitudes and Perceptions of the Human Papillomavirus Vaccine in Caribbean and African American Adolescent boys and Their Parents.

Shao SJ, Nurse C, Michel L, Joseph MA, Suss AL.

J Pediatr Adolesc Gynecol. 2014 Dec 9. pii: S1083-3188(14)00376-3. doi: 10.1016/j.jpag.2014.11.003. [Epub ahead of print]

PMID:
26209867
7.

Risk of spontaneous abortion and other pregnancy outcomes in 15-25 year old women exposed to human papillomavirus-16/18 AS04-adjuvanted vaccine in the United Kingdom.

Baril L, Rosillon D, Willame C, Angelo MG, Zima J, van den Bosch JH, Van Staa T, Boggon R, Bunge EM, Hernandez-Diaz S, Chambers CD.

Vaccine. 2015 Jul 20. pii: S0264-410X(15)00968-8. doi: 10.1016/j.vaccine.2015.07.024. [Epub ahead of print]

PMID:
26206268
8.

Immunization Update V.

Mirza A, Rathore MH.

Adv Pediatr. 2015 Aug;62(1):11-27. doi: 10.1016/j.yapd.2015.04.004. Review. No abstract available.

PMID:
26205107
9.

Prevalence of type-specific HPV among female university students from northern Brazil.

Vieira RC, Monteiro Jdo S, Manso EP, Dos Santos MR, Tsutsumi MY, Ishikawa EA, Ferrari SF, Lima KV, de Sousa MS.

Infect Agent Cancer. 2015 Jul 22;10:21. doi: 10.1186/s13027-015-0017-x. eCollection 2015.

10.

Human papillomavirus in young women with Chlamydia trachomatis infection 7 years after the Australian human papillomavirus vaccination programme: a cross-sectional study.

Chow EP, Danielewski JA, Fehler G, Tabrizi SN, Law MG, Bradshaw CS, Garland SM, Chen MY, Fairley CK.

Lancet Infect Dis. 2015 Jul 17. pii: S1473-3099(15)00055-9. doi: 10.1016/S1473-3099(15)00055-9. [Epub ahead of print]

PMID:
26201300
11.

Parents' preferences and willingness-to-pay for human papilloma virus vaccines in Thailand.

Ngorsuraches S, Nawanukool K, Petcharamanee K, Poopantrakool U.

J Pharm Policy Pract. 2015 Jul 22;8(1):20. doi: 10.1186/s40545-015-0040-8. eCollection 2015.

12.

Human Papillomaviruses; Epithelial Tropisms, and the Development of Neoplasia.

Egawa N, Egawa K, Griffin H, Doorbar J.

Viruses. 2015 Jul 16;7(7):3863-90. doi: 10.3390/v7072802. Review.

13.

Extending the Human Papillomavirus Vaccination Programme to Include Males in High-Income Countries: A Systematic Review of the Cost-Effectiveness Studies.

Ben Hadj Yahia MB, Jouin-Bortolotti A, Dervaux B.

Clin Drug Investig. 2015 Jul 18. [Epub ahead of print]

PMID:
26187455
14.

First generation prophylactic HPV vaccines: The state of the art.

Fruscalzo A, Londero AP, Bertozzi S, Lellé RJ.

Minerva Med. 2015 Jul 17. [Epub ahead of print]

PMID:
26186471
15.

Dissecting the indirect effects caused by vaccines into the basic elements.

Scarbrough Lefebvre CD, Terlinden A, Standaert B.

Hum Vaccin Immunother. 2015 Jul 17:0. [Epub ahead of print]

PMID:
26186100
16.

Recombinant Lactobacillus plantarum induces immune responses to cancer testis antigen NY-ESO-1 and maturation of dendritic cells.

Mobergslien A, Vasovic V, Mathiesen G, Fredriksen L, Westby P, Eijsink VG, Peng Q, Sioud M.

Hum Vaccin Immunother. 2015 Jul 17:0. [Epub ahead of print]

PMID:
26185907
17.

HPV vaccination in boys and men.

Stanley M.

Hum Vaccin Immunother. 2014 Jul;10(7):2106-8. doi: 10.4161/hv.29138.

PMID:
26182341
18.

Human papillomavirus vaccine acceptability among female undergraduate students in China: the role of knowledge and psychosocial factors.

Gu C, Niccolai LM, Yang S, Wang X, Tao L.

J Clin Nurs. 2015 Jul 14. doi: 10.1111/jocn.12871. [Epub ahead of print]

PMID:
26179945
19.

A cross-sectional, multicentre, epidemiological study on human papillomavirus (HPV) type distribution in adult women diagnosed with invasive cervical cancer in Belgium.

Tjalma WA, Trinh XB, Rosenlund M, Makar AP, Kridelka F, Rosillon D, Van Dam PA, Collas De Souza S, Holl K, Simon P, Jenkins D.

Facts Views Vis Obgyn. 2015;7(2):101-8.

20.

State Vaccination Requirements for HPV and Other Vaccines for Adolescents, 1990-2015.

Schwartz JL, Easterling LA.

JAMA. 2015 Jul 14;314(2):185-6. doi: 10.1001/jama.2015.6041. No abstract available.

PMID:
26172898
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk